Literature DB >> 22607558

Assessment of ischaemia-modified albumin level in patients with psoriasis.

M Ozdemir1, A Kiyici, A Balevi, I Mevlitoğlu, C Peru.   

Abstract

BACKGROUND: Ischaemia-modified albumin (IMA) is increased in diseases associated with oxidative stress, as detected using the albumin cobalt-binding test. Oxidative stress plays an important role in the development of psoriasis. AIM: To investigate circulating IMA levels in patients with psoriasis and its association with the disease characteristics.
METHODS: Serum IMA and albumin concentrations were evaluated in 26 patients with psoriasis and 26 healthy controls matched for age, gender and body mass index. Levels of albumin, IMA and adjusted IMA were compared between the groups.
RESULTS: IMA and adjusted IMA were significantly higher in patients with psoriasis [0.55 ± 0.04 and 0.54 ± 0.05 absorbance units (ABSU), respectively] than in healthy controls (0.38 ± 0.04 and 0.38 ± 0.05 ABSU, respectively). The two groups had similar albumin levels, but there was a negative correlation between IMA and albumin levels in patients with psoriasis. IMA did not correlate with any disease characteristics.
CONCLUSIONS: IMA levels are higher in patients with psoriasis than in healthy controls. IMA might be produced through an adaptive response to chronic hypoxia and oxidative stress, which might play a role in the systemic inflammation seen in psoriasis. © The Author(s). CED
© 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607558     DOI: 10.1111/j.1365-2230.2012.04384.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  13 in total

1.  Trace elements and oxidative stress status in patients with psoriasis.

Authors:  Adnan Kirmit; Saadet Kader; Mustafa Aksoy; Ceylan Bal; Cemil Nural; Oruç Aslan
Journal:  Postepy Dermatol Alergol       Date:  2020-04-07       Impact factor: 1.837

2.  Evaluation of serum ischemia modified albumin levels in acute rheumatic fever before and after therapy.

Authors:  Aysun Toker; Zehra Karatas; Hakan Altın; Sevim Karaarslan; Humeyra Cicekler; Hayrullah Alp
Journal:  Indian J Pediatr       Date:  2013-06-28       Impact factor: 1.967

3.  The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations.

Authors:  Firat Uygur; Hakan Tanriverdi; Murat Can; Tacettin Ornek; Fatma Erboy; Bulent Altinsoy; Figen Atalay; Murat Damar; Furuzan Kokturk; Meltem Tor
Journal:  Mediators Inflamm       Date:  2016-01-20       Impact factor: 4.711

4.  The correlation between the psoriasis area severity index and ischemia-modified albumin, mean platelet volume levels in patients with psoriasis.

Authors:  Selda Işik; Sevilay Kılıç; Zerrin Öğretmen; Dilek Ülker Çakır; Hakan Türkön; Sibel Cevizci; Meliha Merve Hız
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

5.  The ischemia modified albumin and mean platelet volume levels in patients with Behçet's disease.

Authors:  Sevilay Kılıç; Selda Işık; Meliha Merve Hiz; Dilek Ülker Çakır; Hakan Türkön; Sibel Cevizci; Zerrin Ogretmen
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

6.  Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet's disease.

Authors:  Ahmet Omma; Sevinc Can Sandikci; Seda Colak; Duygu Tecer; Cigdem Yucel; Zeynep Ozbalkan
Journal:  Postepy Dermatol Alergol       Date:  2018-11-13       Impact factor: 1.837

7.  Assessment of Metabolic Profile and Ischemia-modified Albumin Level in Patients with Alopecia Areata: A Case-Control Study.

Authors:  Pinar Incel-Uysal; Neslihan Akdogan; Nuran Alli; Ayse Oktem; Tuba Candar; Canan Topcuoglu; Turan Turhan
Journal:  Indian J Dermatol       Date:  2019 Jan-Feb       Impact factor: 1.494

Review 8.  Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis.

Authors:  Ilaria Peluso; Arturo Cavaliere; Maura Palmery
Journal:  J Biomed Sci       Date:  2016-07-04       Impact factor: 8.410

9.  Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.

Authors:  Unsal Savci; Engin Senel; Aynure Oztekin; Mustafa Sungur; Ozcan Erel; Salim Neselioglu
Journal:  An Bras Dermatol       Date:  2020-05-06       Impact factor: 1.896

10.  Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia-Modified Albumin Levels in Patients with Diabetic Nephropathy.

Authors:  Mustafa Bilgi; Ahmet Keser; Huseyin Katlandur; Emel Sahin; Ali Osman Kalkan; Murat Yildiz; Aysel Kiyici; Mustafa Keles
Journal:  J Clin Lab Anal       Date:  2016-10-01       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.